Nitish Sharma and Piotr Alvarez compare reverse-phase separations of small molecules vs. peptides, from pI value and hydrophobicity to impurity profiles.
|Articles|January 1, 2000
- January 2000
- Volume 18
- Issue 1
- Pages: 42–44
Separation Technology in Drug Discovery
Author(s)Tim Wehr
Advertisement
This first column of "Drug Discovery" chronicles the development of the drug discovery process and explains how separation technologies fit in the world of drug discovery.
Articles in this issue
almost 27 years ago
The Role of Porous Graphitic Carbon in HPLCalmost 27 years ago
Starting Out Right, Part II – Measuring Satisfactionalmost 27 years ago
A Comparison of CE–MS and LC–MS for Peptide Samplesalmost 27 years ago
Chromatography Data Systems, Part I: The FundamentalsAdvertisement
Related to this article
Meet the expert panel exploring the challenges involved in GLP-1 analysis in this LCGC International Peer Exchange®.
Waters' Erin Chambers says combining column chemistry and particle-physics innovation cut a GLP-1 impurity profiling workflow from three hours to under one.
Advertisement
Advertisement